Sana Biotechnology Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:SANA Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Role	Shares	Max Price
08 Mar 24	SellUS$236,300	Patrick Yang	Individual		25,000	US$9.45
08 Feb 24	BuyUS$9,999,996	Arch Venture Partners, L.P.	Company		1,818,181	US$5.50

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of SANA?
Owner Type	Number of Shares	Ownership Percentage
General Public	1,657,779	0.743%
Individual Insiders	21,491,566	9.63%
VC/PE Firms	70,862,537	31.7%
Institutions	129,257,007	57.9%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 13.3%.

Top Shareholders

Top 25 shareholders own 90.63% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
20.5%	Arch Venture Partners, L.P.	45,860,681	US$116.0m	0%	10.78%
12%	FMR LLC	26,776,152	US$67.7m	19.9%	no data
11.2%	Flagship Pioneering, Inc	25,001,856	US$63.3m	0%	16.35%
5.9%	The Vanguard Group, Inc.	13,183,552	US$33.4m	2.37%	no data
5.29%	BlackRock, Inc.	11,817,380	US$29.9m	6.99%	no data
4.6%	Baillie Gifford & Co.	10,278,084	US$26.0m	-2.77%	0.01%
4.56%	Canada Pension Plan Investment Board	10,175,000	US$25.7m	0%	0.02%
3.97%	Steven Harr	8,856,250	US$22.4m	0%	no data
2.97%	State Street Global Advisors, Inc.	6,627,320	US$16.8m	4.24%	no data
2.63%	Capital Research and Management Company	5,879,035	US$14.9m	-0.04%	no data
2.59%	Hans Edgar Bishop	5,790,489	US$14.6m	0.1%	no data
2.16%	Impresa Management LLC	4,832,423	US$12.2m	0%	6.35%
1.46%	T. Rowe Price Group, Inc.	3,263,288	US$8.3m	-30.2%	no data
1.42%	Geode Capital Management, LLC	3,166,480	US$8.0m	9.55%	no data
1.38%	Crestline Investors Inc.	3,085,624	US$7.8m	-4.34%	0.42%
1.26%	GV Management Company, LLC	2,812,500	US$7.1m	0%	0.44%
1.21%	Richard Mulligan	2,698,121	US$6.8m	-10%	no data
1.07%	Baker Bros. Advisors LP	2,380,949	US$6.0m	0%	0.05%
0.81%	Integral Health Asset Management, LLC	1,800,000	US$4.6m	50%	0.52%
0.77%	Morgan Stanley, Investment Banking and Brokerage Investments	1,716,467	US$4.3m	20.2%	no data
0.69%	Sunil Agarwal	1,550,000	US$3.9m	0%	no data
0.69%	Tavistock Life Sciences	1,545,000	US$3.9m	0%	0.25%
0.51%	Northern Trust Global Investments	1,128,342	US$2.9m	32%	no data
0.48%	Dimensional Fund Advisors LP	1,078,900	US$2.7m	106%	no data
0.47%	Charles Schwab Investment Management, Inc.	1,047,846	US$2.7m	11.2%	no data